| Financial Year |
March 31 2023 |
| Monetary Funds |
138,428,435.85 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
600,000.00 |
| Accounts Receivable |
269,565,772.25 |
| Advances to Suppliers |
11,904,943.51 |
| Other Receivables |
3,035,816.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
152,702,582.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,760,104.49 |
| Total Current Assets |
601,997,654.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
633,025,346.46 |
| Under-construction Projects |
189,574,498.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,725,108.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,731,747.58 |
| Deferred Income Tax Assets |
18,669,694.52 |
| Other Non-Current Assets |
17,033,455.84 |
| Sub-Total of Non-Current Assets |
964,394,969.50 |
| Total Assets |
1,566,392,623.64 |
| Short-Term Loans |
120,113,666.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
158,165,222.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,343,821.46 |
| Taxes Payable |
18,553,359.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,002.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,546,106.02 |
| Other Current Liabilities |
1,061,603.93 |
| Sub-Total of Current Liabilities |
348,808,700.64 |
| Long-term Loans |
202,461,700.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
614,739.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
223,341,052.09 |
| Total Liabilities |
572,149,752.73 |
| Paid-In Capital(Or Share Stock) |
100,800,000.00 |
| Capital Surplus |
581,009,727.64 |
| Surplus Reserve |
18,130,174.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
294,217,061.68 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
994,242,870.91 |
| Owner's Equity（Stockholder's Equity） |
994,242,870.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,566,392,623.64 |
